.Basilea Pharmaceutica's job developing brand-new antifungals has actually gotten a substantial boos...
.Having already gathered up the united state civil liberties to Capricor Therapies' late-stage Duche...
.After dismissing the selection meeting for Applied Rehabs' metabolic condition medicine govorestat,...
.Novo Nordisk is continuing its own press right into hereditary medicines, accepting to pay NanoVati...
.Innovent Biologics has created the instance that its own checkpoint inhibitor-cytokine combination ...
.A period 3 test of Daiichi Sankyo and Merck & Co.'s HER3-directed antibody-drug conjugate (ADC) ...
.5 months after Rakovina Rehabs rotated toward artificial intelligence, the cancer-focused biotech h...
.Ascendis Pharma has become a possible threat to BioMarin's Voxzogo, disclosing phase 3 development ...
.Though Alkeus Pharmaceuticals' oral eye ailment asset fell short to significantly lessen geographic...
.With a triad of biotechs attacking the Nasdaq on Friday, it was simple to miss a smaller-scale soci...
.Invulnerable gate preventions are the superheroes of cancer treatment. Drugs like Bristol Myers Squ...
.Welcome to recently's Chutes & Ladders, our roundup of notable leadership hirings, firings and a...
.Regeneron is actually back with long-lasting follow-up for its LAG-3 prevention and PD-1 inhibitor ...
.AstraZeneca has actually shared an early consider the functionality of its own internal antibody-dr...
.After revealing a period 3 launch based on good midstage outcomes, iTeos and GSK are lastly sharing...
.The FDA should be even more open and also collaborative to unleash a surge in commendations of unco...
.It's an uncommonly hectic Friday for biotech IPOs, with Zenas BioPharma, MBX as well as Bicara Reha...
.Atea Pharmaceuticals' antiviral has neglected one more COVID-19 trial, yet the biotech still keeps ...
.Neurocrine Biosciences' mental illness course pivot has actually fallen short. The biotech was actu...
.Sanofi has brought in a late access to the radioligand event, spending 100 thousand europeans ($ 11...